Related Experiment Videos
Sentinel lymph node mapping in colorectal cancer--a review
1Department of Surgery, Michigan State University College of Human Medicine, Flint, USA. ssahadr@aol.com
The Surgical Clinics of North America
|January 5, 2001
Summary
Sentinel lymph node (SLN) mapping is effective for colorectal cancer, accurately predicting nodal status with over 96% accuracy. This minimally invasive procedure offers a low-cost solution for detecting micrometastasis.
Area of Science:
- Oncology
- Surgical Pathology
- Diagnostic Imaging
Background:
- Sentinel lymph node (SLN) mapping is established for melanoma and breast cancer staging.
- Accurate nodal status determination is crucial for colorectal cancer (CRC) treatment planning.
- Current CRC staging methods may not always detect early nodal micrometastasis.
Purpose of the Study:
- To evaluate the efficacy of SLN mapping in colorectal cancer.
- To review SLN mapping techniques, including in vivo and ex vivo approaches for CRC.
- To identify the limitations and potential pitfalls of SLN mapping in CRC.
Main Methods:
- Review of existing literature on SLN mapping techniques in colorectal cancer.
- Analysis of diagnostic accuracy for nodal micrometastasis detection.
- Comparison of in vivo and ex vivo SLN mapping methods.
Main Results:
- SLN mapping demonstrates high success rates in colorectal cancer staging.
- The procedure accurately predicts nodal status in over 96% of cases.
- SLN mapping for CRC is associated with minimal cost and complications.
Conclusions:
- Sentinel lymph node mapping is a highly successful and accurate method for staging colorectal cancer.
- This technique effectively identifies nodal micrometastasis, improving diagnostic precision.
- SLN mapping offers a safe, cost-effective approach for colorectal cancer management.